How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Business Services · Forecast 2027–2033
New Type Of Artificial Organs Market
- By Organ Type: Artificial Heart, Artificial Kidney (Dialysis Devices), Artificial Liver, Artificial Lung (Oxygenators), Artificial Pancreas
- By Material Technology: Silicone-based Polymers, Hydrogels, Biocompatible Metals, Ceramic Composites, Bioengineered Tissue Scaffolds
- By Application: Temporary Support Devices, Permanent Implantable Organs, Bridge to Transplant, Organ Function Augmentation
- By End User: Hospitals, Specialized Organ Transplant Centers, Home Care Settings, Research and Development Laboratories
- By Technology Platform: Mechanical Pumps, Electromechanical Systems, Biohybrid Organs, 3D Bioprinted Organs
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Artificial Heart leads By Organ Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 300 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 16 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the New Type Of Artificial Organs Market report
A complete, evidence-based study - 12 chapters and 126 sections covering market size, segmentation across 5 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Medtronic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Abbott Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Boston Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →SynCardia Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Carmat
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Abiomed
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Organovo
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Xenotransplantation-focused companies (e.g.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Revivicor)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Humacyte
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Terumo Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Getinge Group
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →LivaNova
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Vascutek Terumo
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →BiVACOR
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Artificial Organ Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Artificial Heart43.3
- Artificial Kidney (Dialysis Devices)9.6
- Artificial Liver9.5
- Artificial Lung (Oxygenators)18.1
- Artificial Pancreas19.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Medtronic13.9
- Abbott Laboratories17.2
- Boston Scientific13.8
- SynCardia Systems6.0
- Carmat10.3
- Abiomed10.8
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America36.1
- Europe20.9
- Asia Pacific18.6
- Latin America14.5
- Middle East and Africa9.9
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Medtronic | 88 | 79 | 92 | 85 | 79 | 94 | 86 |
| Abbott Laboratories | 77 | 72 | 79 | 72 | 80 | 73 | 76 |
| Boston Scientific | 73 | 84 | 75 | 69 | 76 | 71 | 75 |
| SynCardia Systems | 69 | 71 | 58 | 57 | 66 | 69 | 65 |
| Carmat | 62 | 70 | 69 | 77 | 51 | 59 | 65 |
| Abiomed | 49 | 61 | 58 | 54 | 69 | 61 | 59 |
| Organovo | 40 | 41 | 59 | 66 | 59 | 47 | 52 |
| Xenotransplantation-focused companies (e.g. | 35 | 53 | 43 | 37 | 50 | 41 | 43 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Medtronic
- Abbott Laboratories
- Boston Scientific
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Medtronic | ✓ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Abbott Laboratories | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Boston Scientific | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| SynCardia Systems | ✓ | ◐ | − | ◐ | ◐ | ✓ |
| Carmat | ◐ | ◐ | ✓ | ✓ | − | ◐ |
| Abiomed | − | ◐ | ◐ | ◐ | ✓ | ◐ |
| Organovo | − | − | ◐ | ◐ | − | − |
| Xenotransplantation-focused companies (e.g. | − | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader1
Set the pace on share, breadth and innovation.
Challenger2
Strong scale, closing on the leaders.
Contender3
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Organ Type in North America, then scale across New Type Of Artificial Organs Market — a $212M beachhead inside a $3.40B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Artificial Heart
Best fit — highest urgency & budget in Organ Type.
Artificial Kidney (Dialysis Devices)
Strong fit — clear ROI and a fast path to value.
Artificial Liver
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Organ Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Material Technology & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Organ Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win New Type Of Artificial Organs Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
New Type Of Artificial Organs Market is a resilient opportunity — $2.95B by 2033, compounding at 4.8%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.8% CAGR
Demand compounds through 2033, outpacing GDP across Organ Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Organ Type moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Material Technology optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
New Type Of Artificial Organs Market — a $8.45B market by 2033. Plan: grow share from 7.6% to 12.4%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.6% | 12.4% | At risk |
| Revenue | $669M | $1.05B | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 31.6% | 44.1% | Behind |
| Customer retention | 91.9% | 95.1% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Organ Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Material Technology capability
A defensible second engine — invest in Material Technology to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Organ Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Material Technology
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $132M capacity & capability investment
- Greenlight bolt-on M&A in Material Technology
- Authorise North America expansion plan
- Fund R&D program for Organ Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAhead
- Input-cost & supply riskBehind
- Regulatory / policy changeAhead
- Execution & talentOn track
Sales deck · value proposition
Win the New Type Of Artificial Organs Market conversation — a $1.18B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Organ Type
Goal Grow share in Organ Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your New Type Of Artificial Organs Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
New Type Of Artificial Organs Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Business Services · scroll →New Type Of Betaine Softener Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportNew Type Of Flotation Process Of Waste Paper Deinking Agent Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportNew Type Of Metal Fiber Porous Materials Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportNew Type Of Waste Paper Deinking Agent Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportNew York Network Video Recorder (NVR) Market
Market size, share, segmentation and regional forecast.
$312M market · 2025 base year
View reportNew,Pre-owned and Rental Construction Equipment Market
Market size, share, segmentation and regional forecast.
$414M market · 2025 base year
View reportNewborn Genetic Testing Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportNewborn Warm Equipment Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportNews & Magazines App Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportNews TV Application Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportNew-Type Imidazoline And Corrosion Inhibitor Market
Market size, share, segmentation and regional forecast.
$483M market · 2025 base year
View reportNew-Type Phosphating Degreasing Agent Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy